March 19, 2021: New York, NY
Aquavit Pharmaceuticals, Inc. (“Aquavit”) announced today that the United States Patent and Trademark Office (“USPTO”) has granted a new patent to the company. The latest patent (Patent No.: 10,894,062) titled “VITAMIN SUPPLEMENT COMPOSITIONS FOR INJECTION” was granted on January 19, 2021.
The ‘062 patent is directed at improved vitamin supplement compositions formulated for administration to patients from cosmetic to therapeutic applications. The novel compositions covered in the patent can be used to slow the aging process, improve skin conditions, skin appearance, and promote wellness, including treating vitamin deficiency, wound healing, scar prevention and hair loss.
With this notice of allowance from the USPTO, Aquavit has set the stage for novel vitamin compositions that can be administered to treat a specific disease or as a general vitamin supplement. In both fields, the composition will open up a new regimen for both the general public and medical professionals.
"The unique vitamin compositions will be able to target the specific needs of vitamin deficient patients, and the various routes of administrations, from Aquavit’s patented microchannel technology to general intramuscular shots, can personalize the patient experience even more." says Dr. Suhjeon Shin, Pharm.D., at Aquavit.
The patent covers administration of vitamin composition that improves aging-related skin conditions and serves as an important milestone for Aquavit’s focus on mesotherapy. Mesotherapy involves delivering vitamin and mineral compositions through superfine injections. These injections are semi-invasive only entering the second layer of your skin, the mesoderm. The treatment has become exceptionally popular across the world in recent times.
“With this new patent, combined with Aquavit’s novel patented microchannel technology, we are poised and well positioned to introduce mesotherapy in US”
To learn more about the patent, click here.
About Aquavit Pharmaceuticals, Inc.
Aquavit Pharmaceuticals, Inc. is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies. Aquavit Pharmaceuticals, Inc. focuses on personalized medicine to improve patients' health, maximize the efficiency of our medical community, and support the pharmacoeconomics of payers.